Verdad Advisers »

Cullinan Oncology shares owned by Verdad Advisers

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $179k 13k 14.21

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Kynam Capital Management
State Street Corporation
Vanguard Capital Management
Blue Owl Capital Holdings
Rtw Investments
VR Adviser
Geode Capital Management
Siren
Nextech Invest
Boothbay Fund Management
Marshall Wace

View all funds holding Cullinan Oncology